BioSpace News Archive

Treadwell Therapeutics announced today the appointment of J.D. Mowery as Chief Operating Officer (COO).

Evernorth, Cigna Corporation’s health services business, and Kaiser Permanente, one of the nation’s leading integrated health care organizations, announced a new, five-year collaboration aimed at delivering increased convenience, affordability and expanded access to high-quality care for Kaiser Permanente members.

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and MedinCell announced that the U.S. Food and Drug Administration has issued a Complete Response Letter regarding the New Drug Application for TV-46000/mdc-IRM for the treatment of schizophrenia.

Milla Pharmaceuticals Inc., a subsidiary of the Alter Pharma Group, announces U.S. Food and Drug Administration (FDA) has granted approval to the Company’s Abbreviated New Drug Application (ANDA) for a generic version of Mestinon® (Pyridostigmine Bromide Syrup) 60 mg/5mL.